Jane Street Group, LLC Nanobiotix S.A. Transaction History
Jane Street Group, LLC
- $384 Billion
- Q1 2025
A detailed history of Jane Street Group, LLC transactions in Nanobiotix S.A. stock. As of the latest transaction made, Jane Street Group, LLC holds 11,387 shares of NBTX stock, worth $43,612. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,387
Previous 11,387
-0.0%
Holding current value
$43,612
Previous $40,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NBTX
# of Institutions
13Shares Held
6MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ5.62MShares$21.5 Million6.69% of portfolio
-
Black Rock Inc. New York, NY239KShares$915,4000.0% of portfolio
-
Perceptive Advisors LLC New York, NY105KShares$402,3520.02% of portfolio
-
Geode Capital Management, LLC Boston, MA10.2KShares$39,0040.0% of portfolio
-
Morgan Stanley New York, NY6.1KShares$23,3630.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $134M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...